Gotham Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$50.2M Buy
102,065
+29,307
+40% +$15.9M 0.15% 104
2025
Q4
$42.2M Buy
72,758
+982
+1% +$555K 0.15% 101
2025
Q3
$34.8M Sell
71,776
-7,986
-10% -$3.72M 0.15% 116
2025
Q2
$32.3M Buy
79,762
+41,418
+108% +$17.3M 0.19% 55
2025
Q1
$19.1M Buy
38,344
+8,993
+31% +$4.87M 0.16% 128
2024
Q4
$15.3M Buy
29,351
+5,944
+25% +$3.27M 0.14% 161
2024
Q3
$14.5M Buy
23,407
+2,125
+10% +$1.26M 0.15% 148
2024
Q2
$11.8M Buy
21,282
+7,164
+51% +$4.1M 0.15% 128
2024
Q1
$8.21M Buy
14,118
+9,218
+188% +$5.17M 0.12% 199
2023
Q4
$2.6M Buy
4,900
+2,246
+85% +$1.09M 0.05% 515
2023
Q3
$1.34M Buy
2,654
+855
+48% +$456K 0.03% 678
2023
Q2
$939K Sell
1,799
-702
-28% -$379K 0.02% 793
2023
Q1
$1.44M Sell
2,501
-1,798
-42% -$1.01M 0.03% 620
2022
Q4
$2.37M Buy
4,299
+2,330
+118% +$1.23M 0.07% 368
2022
Q3
$999K Buy
1,969
+75
+4% +$42K 0.03% 653
2022
Q2
$1.03M Sell
1,894
-5,089
-73% -$2.8M 0.03% 558
2022
Q1
$4.13M Sell
6,983
-2,561
-27% -$1.47M 0.13% 193
2021
Q4
$6.37M Buy
9,544
+6,863
+256% +$4.28M 0.21% 111
2021
Q3
$1.53M Sell
2,681
-9,953
-79% -$5.46M 0.06% 372
2021
Q2
$6.37M Sell
12,634
-15,202
-55% -$7.17M 0.27% 98
2021
Q1
$12.7M Sell
27,836
-2,136
-7% -$1.02M 0.57% 18
2020
Q4
$14M Buy
29,972
+17,365
+138% +$8.14M 0.46% 33
2020
Q3
$5.57M Buy
12,607
+11,093
+733% +$4.58M 0.18% 169
2020
Q2
$549K Sell
1,514
-1,009
-40% -$338K 0.02% 722
2020
Q1
$716K Buy
2,523
+1,075
+74% +$339K 0.02% 643
2019
Q4
$470K Sell
1,448
-1,715
-54% -$520K 0.01% 832
2019
Q3
$921K Sell
3,163
-13,498
-81% -$3.87M 0.02% 604
2019
Q2
$4.89M Sell
16,661
-23,940
-59% -$6.59M 0.08% 322
2019
Q1
$11.1M Buy
40,601
+1,181
+3% +$294K 0.16% 180
2018
Q4
$8.82M Buy
39,420
+25,830
+190% +$6.06M 0.14% 220
2018
Q3
$3.32M Buy
+13,590
New +$3.13M 0.05% 419
2017
Q3
Sell
-2,478
Closed -$432K 1042
2017
Q2
$432K Sell
2,478
-8,413
-77% -$1.41M 0.01% 774
2017
Q1
$1.67M Buy
+10,891
New +$1.66M 0.02% 577
2016
Q3
Sell
-1,790
Closed -$264K 1046
2016
Q2
$264K Sell
1,790
-2,897
-62% -$428K ﹤0.01% 836
2016
Q1
$664K Buy
+4,687
New +$628K 0.01% 715
2014
Q4
Sell
-3,314
Closed -$403K 1043
2014
Q3
$403K Buy
+3,314
New +$403K ﹤0.01% 800

Other funds holding TMO

Gotham Asset Management's TMO Position: Q1 2026 in Review

Gotham Asset Management increased its Thermo Fisher Scientific (TMO) stake by 40% in Q1 2026, buying an estimated $15.9M and bringing the position to 102,065 shares worth $50.2M. The position accounts for 0.15% of the portfolio, ranked #104.

Gotham Asset Management first reported a position in TMO in Q3 2014 and has held it in 36 quarters since. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Gotham Asset Management held 102,065 shares of Thermo Fisher Scientific worth $50.2M as of Q1 2026.
  • Gotham Asset Management bought 29,307 Thermo Fisher Scientific shares in Q1 2026, an estimated $15.9M.
  • Thermo Fisher Scientific made up 0.15% of Gotham Asset Management's portfolio in Q1 2026, its #104 holding.
  • Gotham Asset Management first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 36 quarters since.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.